|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hsu WH, Yang JC, Mok TS and Loong HH:
Overview of current systemic management of EGFR-mutant NSCLC. Ann
Oncol. 29 (Suppl 1):i3–i9. 2018. View Article : Google Scholar
|
|
3
|
Fan J, Fong T, Xia Z, Zhang J and Luo P:
The efficacy and safety of ALK inhibitors in the treatment of
ALK-positive non-small cell lung cancer: A network meta-analysis.
Cancer Med. 7:4993–5005. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Borghaei H, Paz-Ares L, Horn L, Spigel DR,
Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, et al:
Nivolumab versus docetaxel in advanced nonsquamous no-small-cell
lung cancer. N Engl J Med. 373:1627–1639. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herbst RS, Baas P, Kim DW, Felip E,
Perez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, et al:
Pembrolizumab versus docetaxel for previously treated,
PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010):
A randomized controlled trial. Lancet. 387:1540–1550. 2016.
View Article : Google Scholar
|
|
6
|
Garon EB, Rizvi NA, Hui R, Leighl N,
Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L,
et al: Pembrolizumab for the treatment of non-small-cell lung
cancer. N Engl J Med. 372:2018–2028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mantovani A, Marchesl F, Malesci A, Laghi
L and Allavena P: Tumor-associated macrophages as treatment targets
in oncology. Nat Rev Clin Oncol. 14:399–416. 2017. View Article : Google Scholar
|
|
9
|
Mei J, Xiao Z, Guo C, Pu Q, Ma L, Liu C,
Lin F, Liao H, You Z and Liu L: Prognostic impact of
tumor-associated macrophage infiltration in non-small cell lung
cancer: A systemic review and meta-analysis. Oncotarget.
7:34217–34228. 2016. View Article : Google Scholar
|
|
10
|
Jackute J, Zemaitis M, Pranys D,
Sitkauskiene B, Miliauskas S, Vaitkiene S and Sakalauskas R:
Distribution of M1 and M2 macrophages in tumor islets and stroma in
relation to prognosis of non-small cell lung cancer. BMC Immunol.
19:32018. View Article : Google Scholar
|
|
11
|
van Dalen FJ, van Stevendaal MHME,
Fennemann FL, Verdoes M and Ilina O: Molecular repolarisation of
tumour-associated macrophages. Molecules. 24:92018. View Article : Google Scholar
|
|
12
|
Medrek C, Ponten F, Jirstrom K and
Leandersson K: The presence of tumor associated macrophages in
tumor stroma as a prognostic marker for breast cancer patients. BMC
Cancer. 12:3062012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen JJW, Yao PL, Yuan A, Hong TM, Shun
CT, Kuo ML, Lee YC and Yang PC: Up-regulation of tumor
interleukin-8 expression by infiltrating macrophages: Its
correlation with tumor angiogenesis and patient survival in
non-small cell lung cancer. Clin Cancer Res. 9:729–737.
2003.PubMed/NCBI
|
|
14
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: Tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002. View Article : Google Scholar
|
|
15
|
Boutilier AJ and Elsawa SF: Macrophage
polarization states in the tumor microenvironment. Int J Mol Sci.
22:69952021. View Article : Google Scholar
|
|
16
|
Sumitomo R, Hirai T, Fujita M, Murakami H,
Otake Y and Huang CL: M2 tumor-associated macrophages promote tumor
progression in non-small-cell lung cancer. Exp Ther Med.
18:4490–4498. 2019.PubMed/NCBI
|
|
17
|
Yang Y, Ye YC, Chen Y, Zhao JL, Gao CC,
Han H, Liu WC and Qin HY: Crosstalk between hepatic tumor cells and
macrophages via Wnt/β-catenin signaling promotes M2-like macrophage
polarization and reinforces tumor malignant behaviors. Cell Death
Dis. 9:7932018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye YC, Zhao JL, Lu YT, Gao CC, Yang Y,
Liang SQ, Lu YY, Wang L, Yue SQ, Dou KF, et al: NOTCH signaling via
WNT regulates the proliferation of alternative, CCR2-independent
tumor-associated macrophages in hepatocellular carcinoma. Cancer
Res. 79:4160–4172. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tian X, Wu Y, Yang Y, Wang J, Niu M, Gao
S, Qin T and Bao D: Long noncoding RNA LINC00662 promotes M2
macrophage polarization and hepatocellular carcinoma progression
via activating Wnt/β-catenin signaling. Mol Oncol. 14:462–483.
2020. View Article : Google Scholar
|
|
20
|
Liu Q, Yang C, Wang S, Shi D, Wei C, Song
J, Lin X, Dou R, Bai J, Xiang Z, et al: Wnt5a-induced M2
polarization of tumor-associated macrophages via IL-10 promoted
colorectal cancer progression. Cell Commun Signal. 18:512020.
View Article : Google Scholar
|
|
21
|
Jiang Y, Han Q, Zhao H and Zhang J:
Promotion of epithelial-mesenchymal transformation by
hepatocellular carcinoma-educated macrophages through
Wnt2b/β-catenin/c-Myc signaling and reprogramming glycosis. J Exp
Clin Cancer Res. 40:132021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dale TC: Signal transduction by the Wnt
family of ligands. Biochem J. 329:209–223. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
You Z, Saims D, Chen S, Zhang Z, Guttridge
DC, Guan KL, MacDougald OA, Brown AMC, Evan G, Kitajewski J and
Wang CY: Wnt signaling promotes oncogenic transformation by
inhibiting c-Myc-induced apoptosis. J Cell Biol. 157:429–440. 2002.
View Article : Google Scholar
|
|
24
|
Miller JR, Hocking AM, Brown JD and Moon
RT: Mechanism and function of signal transduction by the
Wnt/β-catenin and Wnt/Ca2+ pathways. Oncogene.
18:7860–7872. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang C, Liu D, Nakano J, Ishikawa S,
Kontani K, Yokomise H and Ueno M: Wnt5a expression is associated
with the tumor proliferation and the stromal vascular endothelial
growth factor-A expression in non-small-cell lung cancer. J Clin
Oncol. 23:8765–8773. 2005. View Article : Google Scholar
|
|
26
|
Huang C, Liu D, Ishikawa S, Nakashima T,
Nakashima N, Yokomise H, Kadota K and Ueno M: Wnt1 overexpression
promoted tumour progression in non-small cell lung cancer. Eur J
Cancer. 44:2680–2688. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu D, Kadota K, Ueno M, Nakashima N,
Yokomise H and Huang CL: Adenoviral vector expressing short hairpin
RNA targeting Wnt2B has an effective antitumour activity against
Wnt2B2–overexpressing tumors. Eur J Cancer. 48:1208–1218. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakashima N, Liu D, Huang CL, Ueno M,
Zhang X and Yokomise H: Wnt3 gene expression promotes tumor
progression in non-small cell lung cancer. Lung Cancer. 76:228–234.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scagliotti GV, Micela M, Gubetta L,
Leonardo E, Cappia S, Borasio P and Pozzi E: Prognostic
significance of Ki67 labelling in resected non small cell lung
cancer. Eur J Cancer. 29A:363–365. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Amin MB, Edge S and Greene F: AJCC Cancer
Staging Manual. 8th edition. Springer; New York, NY, USA: 2017,
View Article : Google Scholar
|
|
31
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: WHO classification of tumours of the lung,
pleura, thymus and heart. J Thorac Oncol. 10:1240–1242. 2015.
View Article : Google Scholar
|
|
32
|
Li Z, Maeda D, Yoshida M, Umakoshi M,
Nanjo H, Shiraishi K, Saito M, Kohno T, Konno H, Saito H, et al:
The intratumoral distribution influences the prognostic impact of
CD68- and CD204-positive macrophages in non-small cell lung cancer.
Lung Cancer. 123:127–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shrotriya S, Walsh D, Bennani-Baiti N,
Thomas S and Lorton C: C-reactive protein is an important biomarker
for prognosis tumor recurrence and treatment response in adult
solid tumors: A systematic review. PLoS One. 10:e01430802015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei C, Yang C, Wang S, Shi D, Zhang C, Lin
X, Liu Q, Dou R and Xiong B: Crosstalk between cancer cells and
tumor associated macrophages is required for mesenchymal
circulating tumor cell-mediated colorectal cancer metastasis. Mol
Cancer. 18:642019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin X, Wang S, Sun M, Zhang C, Wei C, Yang
C, Dou R, Liu Q and Xiong B: miR-195-5p/NOTCH2-mediated EMT
modulates IL-4 secretion in colorectal cancer to affect M2-like TAM
polarization. J Hematol Oncol. 12:202019. View Article : Google Scholar
|
|
36
|
Ruffell B, Affara NI and Coussens LM:
Differential macrophage programming in the tumor microenvironment.
Trends Immunol. 33:119–126. 2012. View Article : Google Scholar
|
|
37
|
Su S, Liu Q, Chen J, Chen J, Chen F, He C,
Huang D, Wu W, Lin L, Huang W, et al: A positive feedback loop
between mesenchymal-like cancer cells and macrophages is essential
to breast cancer metastasis. Cancer Cell. 25:605–620. 2014.
View Article : Google Scholar
|
|
38
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View Article : Google Scholar
|
|
39
|
Galdiero MR, Bonavita E, Barajon I,
Garlanda C, Mantovani A and Jaillon S: Tumor associated macrophages
and neutrophils in cancer. Immunobiology. 218:1402–1410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Katoh M: WNT/PCP signaling pathway and
human cancer (review). Oncol Rep. 14:1583–1588. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Korinek V, Barker N, Morin PJ, van Wichen
D, de Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive
transcriptional activation by a β-catenin-Tcf complex in
APC−/− colon carcinoma. Science. 275:1784–1787. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinomas cells.
Nature. 398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang X, Gaspard JP and Chung DC:
Regulation of vascular endothelial growth factor by the Wnt and
K-ras pathways in colonic neoplasia. Cancer Res. 61:6050–6054.
2001.PubMed/NCBI
|
|
45
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee TH, Tai DI, Cheng CJ, Sun CS, Lin CY,
Sheu MJ, Lee WP, Peng CY, Wang AH and Tsai SL: Enhanced nuclear
factor-kappa B-associated Wnt-1 expression in hepatitis B- and
C-related hepatocarcinogenesis: Identification by functional
proteomics. J Biomed Sci. 13:27–39. 2006. View Article : Google Scholar
|
|
47
|
Jönsson M, Smith K and Harris AL:
Regulation of Wnt5a expression in human mammary cells by protein
kinase C activity and the cytoskeleton. Br J Cancer. 78:430–438.
1998. View Article : Google Scholar
|
|
48
|
Huang C, Liu D, Masuya D, Kameyama K,
Nakashima T, Yokomise H, Ueno M and Miyake M: MRP-1/CD9 gene
transduction downregulates Wnt signal pathways. Oncogene.
23:7475–7483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Patel S, Alam A, Pant R and Chattopadhyay
S: Wnt signaling and its significance within the tumor
microenvironment: Novel therapeutic insights. Front Immunol.
10:28722019. View Article : Google Scholar
|
|
50
|
Liu Q, Song J, Pan Y, Shi D, Yang C, Wang
S and Xiong B: Wnt5a/CaMKII/ERK/CCL2 axis is required for
tumor-associated macrophages to promote colorectal cancer
progression. Int J Biol Sci. 16:1023–1034. 2020. View Article : Google Scholar
|
|
51
|
Zhang L, Zeng S, Yu Z, Zhang G, Xiong Z,
Xie F and You Z: Overexpression of activating transcription
factor-2 (ATF-2) activates Wnt/Ca2+ signaling pathways and promotes
proliferation and invasion in non-small-cell lung cancer. Dis
Markers. 2:57720892022.
|
|
52
|
He X, Saint-Jeannet JP, Wang Y, Nathans J,
Dawid I and Varmus H: A member of the Frizzled protein family
mediating axis induction by Wnt-5A. Science. 275:1652–1654. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kobayashi M, Huang C, Sonobe M, Kikuchi R
and Date H: Ad-shWnt2b vector therapy demonstrates antitumor
activity in orthotopic intrapleural models as monitored with the in
vitro imaging system (IVIS). Anticancer Res. 36:5887–5894. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lila AS, Fukushima M, Huang C, Wada H and
Ishida T: Systemically administered RNAi molecules sensitizes
malignant pleural mesotheliomal cells to pemetrexed therapy. Mol
Pharm. 13:3955–3963. 2016. View Article : Google Scholar : PubMed/NCBI
|
